Tevogen to Share Direct Registration System (DRS) Process Details Following Increased Shareholder Interest
Tevogen Bio Holdings (NASDAQ: TVGN) has announced plans to provide detailed guidance on the Direct Registration System (DRS) process in response to increased shareholder inquiries.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Tevogen Bio Holdings (NASDAQ: TVGN) has announced plans to provide detailed guidance on the Direct Registration System (DRS) process in response to increased shareholder inquiries. The announcement follows growing interest from shareholders seeking information on transferring their shares to DRS accounts. The company revealed that several of its major shareholders, both internal and external, have already opted for DRS as their preferred method of share ownership, demonstrating confidence in this direct ownership approach.
The company will release step-by-step instructions next week to assist shareholders in registering their shares directly with Continental Stock Transfer & Trust, Tevogen's transfer agent.
Details
News Market Reaction – TVGNW
The recorded move for TVGNW in the trading session of this news was +0.21%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WARREN, N.J., May 02, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced that, following the Company’s recent press release highlighting the Direct Registration System (DRS) as a secure method of share ownership, it has received a number of inquiries from shareholders seeking additional information on how to transfer their shares to a DRS account.
In response, Tevogen will provide step-by-step guidance early next week to help interested shareholders register their shares directly with the Company’s transfer agent, Continental Stock Transfer & Trust.
The Company also notes that several of its largest shareholders, both internal and external, have elected to hold their shares via DRS, underscoring their confidence in this method of direct ownership.
Contacts
Tevogen Bio Communications
T: 1 877 TEVOGEN, Ext 701
Communications@Tevogen.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.